1 June 2022
Harm Jan Bogaard, Amsterdam UMC, the Netherlands
Kelly Morland, United Therapeutics, USA
The use of master protocols and a platform design: lessons from COVID-19 therapeutic trials
Presenter: // Lisa Lavange, University of North Carolina, USA
A platform trial and master protocol for PAH clinical trials: is it feasible, and if so, which drugs do we want to study?
Panel discussion: // Ardeschir Ghofrani, Roham Zamanian, CQ Deng & Mardi Gomberg-Maitland
The use of RWD/RWE in bringing drugs to PH patients
Presenter: // Steve Mathai, Johns Hopkins University, USA
RWD/RWE in PH: what are the questions and can we get the answers?
Panel discussion: //
Through worldwide collaboration, we can begin to answer the question of a global disease.